Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells

Journal article

Peer reviewed

N Eliopoulos, A AL-KHALDI, C. M Beausejour, R. L Momparler, L. F Momparler and J Galipeau

Gene therapy, Vol.9(7), pp.452-462

01/04/2002

PMID: 11938460

Abstract

Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy

Applied cell therapy and gene therapy

Biological and medical sciences

Biotechnology

Fundamental and applied biological sciences. Psychology

Gene therapy

Health. Pharmaceutical industry

Industrial applications and implications. Economical aspects

Medical sciences

Transfusions. Complications. Transfusion reactions. Cell and gene therapy

1 Record Views

Title: Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells
Creators - without role: N Eliopoulos - McGill University
A AL-KHALDI - McGill University Health Centre
C. M Beausejour - Université de Montréal
R. L Momparler - Université de Montréal
L. F Momparler - Université de Montréal
J Galipeau - Jewish General Hospital
Publication Details: Gene therapy, Vol.9(7), pp.452-462
Publisher: Nature Publishing Group
Identifiers: 9920668308331
Academic Unit: King Abdulaziz University
Language: English
Resource Type: Journal article